Yue Wu is currently an Advisor at Eli Lilly and Company, where they develop innovative gene editing medicines to treat cardiovascular and other diseases. Previously, Yue held the position of Associate Principal Scientist at Verve Therapeutics, leading computational biology initiatives and enhancing team productivity through engineered web applications. They were a Research Fellow at both Harvard Medical School and Massachusetts General Hospital, focusing on transcriptional signaling networks. Yue gained additional experience as a Staff Fellow at the FDA, working on various projects including artificial intelligence and genomics. They earned a Ph.D. in Biotechnology from Brock University and a B.Sc. in Biotechnology from China Pharmaceutical University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices